Related Experiment Video
Updated: Apr 14, 2026
11:30
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
2.7K
Vascular calcification in chronic kidney disease: an update
Georg Schlieper1, Leon Schurgers2, Vincent Brandenburg3
1Department of Nephrology, RWTH University of Aachen, Aachen, Germany.
Summary
Cardiovascular calcification, a risk factor for disease and death, accelerates in patients with chronic kidney disease or diabetes. Preventing this calcification by balancing promoters and inhibitors is key, as reversing it is difficult.
Area of Science:
- Cardiovascular research
- Nephrology
- Endocrinology
Background:
- Cardiovascular calcification contributes significantly to morbidity and mortality.
- Patients with chronic kidney disease and/or diabetes experience accelerated calcification in various cardiovascular tissues.
- Calcific uraemic arteriolopathy (calciphylaxis) is a rare but severe manifestation.
Purpose of the Study:
- To review the pathomechanisms of cardiovascular calcification, particularly in chronic kidney disease and diabetes.
- To discuss current therapeutic strategies focusing on prevention.
- To highlight the challenges and current research in the therapeutic regression of established calcifications.
Main Methods:
- Review of existing literature on cardiovascular calcification.
- Analysis of pathomechanistic pathways involving promoters and inhibitors.
- Examination of cellular processes in vascular calcification.
- Overview of therapeutic approaches and clinical trials.
Main Results:
- An imbalance of calcification promoters (calcium, phosphate) and inhibitors (fetuin-A, matrix Gla protein) is central to pathogenesis.
- Cellular processes, including vascular smooth muscle cell osteochondrogenesis and senescence, play a role.
- Preventive measures targeting the promoter-inhibitor balance are essential.
- Therapeutic regression of established cardiovascular calcification in humans is rarely reported.
Conclusions:
- Preventing cardiovascular calcification by correcting biochemical and cellular imbalances is crucial.
- Effective therapeutic strategies for reversing existing calcification are limited.
- Ongoing clinical trials are investigating secondary prevention in patients with established cardiovascular calcification.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
1.0K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
01:25Chronic Kidney Disease I: Introduction
1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
01:28Chronic Kidney Disease III: Interprofessional Care
645
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
645
01:18Chronic Kidney Disease IV: Nursing Management
655
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
655
01:21Skeleton and Calcium Homeostasis
9.5K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
9.5K
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
913
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
913